) was a big mover last session, as the company saw its shares
rise by over 18% on the day. The move came on solid volume too
with far more shares changing hands than in a normal session.
This continues the recent uptrend for the company, as the stock
has now gained over 43% in the past one month time frame.
This biotechnology company has seen no estimate revision over the
past 30 days while its Zacks Consensus Estimate moved lower over
the same time frame, suggesting there may be trouble down the
road. So make sure to keep an eye on this stock going forward to
see if this recent move higher can last.
MannKind currently has a Zacks Rank #3 (Hold) while its
Some better-ranked stocks in the same industry include
Genomic Health Inc.
). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
AFFYMETRIX INC (AFFX): Free Stock Analysis
GENTIUM SPA-ADR (GENT): Free Stock Analysis
GENOMIC HEALTH (GHDX): Free Stock Analysis
MANNKIND CORP (MNKD): Free Stock Analysis
To read this article on Zacks.com click here.